ZSNeo-DC
/ ZSky BioTech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 08, 2026
ZSNeo-DC-RWS: Personalized Neoantigen-pulsed Autologous Dendritic Cell Injections for Malignant Solid Tumors
(clinicaltrials.gov)
- P=N/A | N=100 | Recruiting | Sponsor: ZSky Biotech Inc
New trial • Real-world evidence • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1